Founded in 2015, Avegen is a healthcare technology startup based in Pune and London.
Avegen creates digital care programs that claim to be personalized, patient-centered, and evidence-based.
Its HealthMachine platform is software as a service (SaaS) that deploys these digital care programs that improve the health of people with long-term conditions. These digital care programs, based on a compatible and scalable platform, are designed around the patient and enable proactive care for patients with chronic conditions and support clinicians in improved patient management.
Apt says: “The team is split between Pune and London. Nayan is headquartered in London and leads our sales and customer service team. The product development and program management team are from India. Nayan and I have been in touch since 2006-07. While selling my previous business, Nayan was also looking to start something. Essentially, we decided it was a good time to meet and we started this company at the end of 2015 ”.
HealthMachine: drive digital care programs
HealthMachine puts each patient in control of their own health, monitors progress, and reinforces results. Easy-to-use features and gamification touches make HealthMachine-based care programs intuitive and effective, eliminating traditional barriers. Avegen currently has three digital care programs at HealthMachine:
• Cardiac rehabilitation
• Maternal health
“Together for her” in India
Kalnad explained the digital care program for women, “Avegen has been working in the digital health space since 2015 in both India and the UK. Avegen’s vision is to transform healthcare through technology and we work in multiple areas of disease and care, including cardio-pulmonary care, HIV and maternal health. Together for Her (TFH), our maternal care program began in 2017 with the vision of improving the quality of maternal care and reducing preventable maternal deaths. “
Kalnad claims that TFH is a fully digital care program for pregnant women with more than 30,000 users today.
The app provides gestational week-specific information on recommended medical behaviors, as well as data-based feedback on their nutritional and prenatal behaviors.
In addition, TFH uses machine learning and predictive analytics to provide personalized maternal health information based on the health status of the pregnant woman.
“First of all, we want to reduce deaths during pregnancy. Regarding the impact on women’s health, we aim to reduce the prevalence of anemia in mothers who use the application by at least 20%, compared to the usual treatment. In addition, we aim to have 25 lakh mothers in our TFH program in the next five years, ”Kalnad adds.
Gupte says he explains: “We all consume a lot of technology every day. However, the most advanced and powerful technology is unfortunately aimed at making us buy something instead of improving our lives. What moves me is to use the same technology to have a positive impact on people’s lives. India is a hub for sending software and IT projects to the world, but we do not develop world class software for Indian consumers. We wanted to change that, and so we developed TFH which is available to Indian users in English and Hindi. “
Provide relevant content
Gupte says: “The content of the platform changes in two dimensions. Relevant and fresh content is regularly developed, while in terms of personalization, when a mom signs up, we create a profile based on areas of interest. Pregnancy is a definite nine-month journey, and so week by week, certain content becomes more relevant. Therefore, the respective content is displayed accordingly “.
Avegen HealthMachine’s largest customers are pharmaceutical companies and hospitals in the UK. In India, doctors and non-governmental organizations (NGOs) are the first adopters.
“Avegen also helped a Bombay-based NGO build a helpline for HIV-positive patients during the first closure in the country in March 2020,” Gupte says.
Merck for Mothers (MFM) has been a financing partner of Avegen since 2017. MFM has supported the development of TFH, which was started as a platform for reviewing the quality of care and has since been has become the current maternal care program. MFM works with partners around the world to support innovative solutions that aim to end maternal deaths.
As for Avegen, Dr. Kalnad says: “We are a company with initial starts. The initial investment was mainly from friends and family. In 2016 we had raised about $ 250,000. This year we want to raise a new round of funding of between 28 and 30 million euros to expand them in Europe. We want to be the first or large company originating in India to grow in the space of digital therapy and digital care program. ”